Announcements Trials
Browse Landscape

Phase

Phase 2 16Phase 1 5Phase 1/2 4Phase 3 3Phase 4 2

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3

Conditions

Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Lymphoma, B-Cell 1Lymphoma 1

Interventions

Cisplatin 725Carboplatin 607Paclitaxel 578Cyclophosphamide 516Radiotherapy 511Docetaxel 475Fluorouracil 453Gemcitabine 437Doxorubicin 383Capecitabine 361Dexamethasone 327Oxaliplatin 288pembrolizumab 283Leucovorin 282Bevacizumab 275Etoposide 271Vincristine 270Rituximab 246Prednisone 222Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 175Irinotecan 172Methotrexate 171Lenalidomide 137Nivolumab 135Filgrastim 135Epirubicin 129Tamoxifen 127

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × axicabtagene ciloleucel × Clear all
NCT07188558 2026-03-04

PiNACLE-H2H

Lyell Immunopharma, Inc.

Phase 3 Recruiting
400 enrolled
Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT03391466 2025-12-01

ZUMA-7

Gilead Sciences

Phase 3 Completed
359 enrolled 27 charts
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT05371093 2025-10-15

ZUMA-22

Gilead Sciences

Phase 3 Active not recruiting
231 enrolled
Lymphoid

Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡